Representative Publications: |
Eggener SE, Vickers AJ, Serio AM, Donovan MJ, Khan FM, Bayer-Zubek V, Verbel D, Cordon-Cardo C, Reuter VE, Bianco FJ Jr, Scardino PT. Comparison of models to predict clinical failure after radical prostatectomy Cancer 2009; 115(2):303-10
|
Eggener SE. The clinical diversity of postchemotherapy germ cell teratoma. Cancer 2009; 115 (6):1138-41
|
Kundu SD, Eggener SE. Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter Adv Urology 2009
|
Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B.. A multi-institutional evaluation of active surveillance for low risk prostate cancer J Urol 2009; 181(4):1635-41
|
Jayram G, Eggener SE. Patient selection for focal therapy of localized prostate cancer Curr Opin Urol 2009; 19(3):268-73
|
Katz MH, Eggener SE. The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates World J Urol. 2009; 27(4):477-83
|
Shikanov S, Wille M, Large M, Lifshitz DA, Zorn KC, Shalhav AL, Eggener SE. Knotless closure of the collecting system and renal parenchyma with a novel barbed suture during laparoscopic porcine partial nephrectomy. J Endourol 2009; 23(7):1157-60
|
Alur M, Nguyen MM, Eggener SE, Jiang F, Dadras SS, Stern J, Kimm S, Roehl K, Kozlowski J, Pins M, Michalak M, Dhir R, Wang Z.. Suppressive roles of calreticulin in prostate cancer growth and metastasis. Am J Pathol 2009; 175(2):882-90
|
Lifshitz DA, Shikanov S, Jeldres C, Deklaj T, Karakiewicz PI, Zorn KC, Eggener SE, Shalhav AL. Laparoscopic partial nephrectomy: predictors of prolonged warm ischemia. J Urol 2009; 182(3):860-5
|
Zorn KC, Gautam G, Shalhav AL, Clayman RV, Ahlering TE, Albala DM, Lee DI, Sundaram CP, Matin SF, Castle EP, Winfield HN, Gettman MT, Lee BR, Thomas R, Patel VR, Leveillee RJ, Wong C, Badlani GH, Rha KH, Eggener SE, Wiklund P, Mottrie A, Atug F, Kural AR, Joseph JV. Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol 2009; 182(3):1126-32
|
Eggener SE, Yossepowitch O, Kundu S, Motzer RJ, Russo P. Risk Score and Metastasectomy Independently Impact Prognosis of Patients With Recurrent Renal Cell Carcinoma. J Urol 2008
|
Eggener SE, Guillonneau B. Laparoscopic radical prostatectomy: ten years later, time for evidence-based foundation. Eur Urol 2008; 54(1):4-7
|
Thong AE, Shikanov S, Katz MH, Gofit ON, Eggener S, Zagaja GP, Shalhav AL, Zorn KC. A single microfocus (5% or less) of Gleason 6 prostate cancer at
biopsy--can we predict adverse pathological outcomes? J Urol 2008; 180(6):2436-40
|
Sharp DS, Carver BS, Eggener SE, Kondagunta GV, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 2008; 26(34):5524-9
|
Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol 2007; 177(3):937-42; discussion 942-3
|
Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, Sheinfeld J. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer 2007; 109(3):528-35
|
Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L, . Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178(6):2260-7
|
Shikanov S, Song J, Royce C, Al-Ahmadie H, Zorn K, Steinberg G, Zagaja G, Shalhav A, Eggener S.. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence J Urol 2007; 182(1):139-44
|
Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 2006; 24(19):3101-6
|
Eggener SE, Stern JA, Jain PM, Oram S, Ai J, Cai X, Roehl KA, Wang Z. Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model. Prostate 2006; 66(5):495-502
|
Eigl BJ, Eggener SE, Baybik J, Ettinger S, Chi KN, Nelson C, Wang Z, Gleave ME. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clin Cancer Res 2005; 11(13):4905-11
|
Eggener SE, Rubenstein JN, Smith ND, Nadler RB, Kontak J, Flanigan RC, Waters WB, Picken M, Campbell SC, Rubenstein JR. Renal tumors in young adults. J Urol 2004; 171(1):106-10
|
|
|
|
